Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 7/2019

26.11.2018 | Original Article

Preferences for Surveillance of Barrett’s Oesophagus: a Discrete Choice Experiment

verfasst von: Norma B. Bulamu, Gang Chen, Tim Bright, Julie Ratcliffe, Adrian Chung, Robert J. L. Fraser, Björn Törnqvist, David I. Watson

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Endoscopic surveillance for Barrett’s oesophagus is undertaken to detect dysplasia and early cancer, and to facilitate early intervention. Evidence supporting current practice is of low quality and often influenced by opinion. This study investigated the preferences of patients for surveillance of Barrett’s oesophagus in an Australian cohort.

Methods

Four Barrett’s oesophagus surveillance characteristics/attributes were evaluated within a discrete choice experiment based on literature and expert opinion: (1) surveillance method (endoscopy vs a blood test vs a novel breath test), (2) risk of missing a cancer over a 10-year period, (3) screening interval, and (4) out-of-pocket cost. The data from the discrete choice experiment was analysed within the framework of random utility theory using a mixed logit regression model.

Results

The study sample comprised patients (n = 71) undergoing endoscopic surveillance for Barrett’s oesophagus of whom n = 65 completed the discrete choice experiment. The sample was predominantly male (77%) with average age of 65 years. All attributes except surveillance method significantly influenced respondents’ preference for Barrett’s oesophagus surveillance. Policy analyses suggested that compared to the reference case (i.e. endoscopy provided annually at no upfront cost and with a 4% risk of missing cancer), increasing test sensitivity to 0.5% risk of missing cancer would increase participation by up to 50%; surveillance every 5 years would lead to 26% reduction, while every 3 to 3.5 years would result in 7% increase in participation. Respondents were highly averse to paying A$500 for the test, resulting in 48% reduction in participation. None of the other surveillance methods was preferred to endoscopy, both resulting in 11% reduction in participation.

Conclusion

Test sensitivity, test frequency and out-of-pocket cost were the key factors influencing surveillance uptake. Patients prefer a test with the highest sensitivity, offered frequently, that incurs no upfront costs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Stavrou EP, McElroy HJ, Baker DF, Smith G, Bishop JF: Adenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972–2005. Medical Journal of Australia 2009, 191(6):310–314.PubMed Stavrou EP, McElroy HJ, Baker DF, Smith G, Bishop JF: Adenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972–2005. Medical Journal of Australia 2009, 191(6):310–314.PubMed
2.
Zurück zum Zitat Thrift AP, Whiteman DC: The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Annals of Oncology 2012, 23(12):3155–3162.CrossRefPubMed Thrift AP, Whiteman DC: The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Annals of Oncology 2012, 23(12):3155–3162.CrossRefPubMed
3.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A: Cancer statistics, 2017. CA: A Cancer Journal for Clinicians 2017, 67(1):7–30. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2017. CA: A Cancer Journal for Clinicians 2017, 67(1):7–30.
4.
Zurück zum Zitat Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S et al: British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 2014, 63(1):7–42.CrossRefPubMed Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S et al: British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 2014, 63(1):7–42.CrossRefPubMed
5.
Zurück zum Zitat Whiteman DC, Appleyard M, Bahin FF, Bobryshev YV, Bourke MJ, Brown I, Chung A, Clouston A, Dickins E, Emery J et al: Australian clinical practice guidelines for the diagnosis and management of Barrett’s esophagus and early esophageal adenocarcinoma. Journal of Gastroenterology and Hepatology 2015, 30(5):804–820.CrossRefPubMed Whiteman DC, Appleyard M, Bahin FF, Bobryshev YV, Bourke MJ, Brown I, Chung A, Clouston A, Dickins E, Emery J et al: Australian clinical practice guidelines for the diagnosis and management of Barrett’s esophagus and early esophageal adenocarcinoma. Journal of Gastroenterology and Hepatology 2015, 30(5):804–820.CrossRefPubMed
6.
Zurück zum Zitat Shaheen NJ, Falk GW, Iyer PG, Gerson LB: ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. American Journal of Gastroenterology 2016, 111(1):30–50.CrossRefPubMed Shaheen NJ, Falk GW, Iyer PG, Gerson LB: ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. American Journal of Gastroenterology 2016, 111(1):30–50.CrossRefPubMed
7.
Zurück zum Zitat Mansfield C, Tangka FKL, Ekwueme DU, Smith JL, Guy GP, Li C, Hauber AB: Stated Preference for Cancer Screening: A Systematic Review of the Literature, 1990–2013. Preventing Chronic Disease 2016, 13:E27.CrossRefPubMedPubMedCentral Mansfield C, Tangka FKL, Ekwueme DU, Smith JL, Guy GP, Li C, Hauber AB: Stated Preference for Cancer Screening: A Systematic Review of the Literature, 1990–2013. Preventing Chronic Disease 2016, 13:E27.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Chan DK, Zakko L, Visrodia KH, Leggett CL, Lutzke LS, Clemens MA, Allen JD, Anderson MA, Wang KK: Breath Testing for Barrett’s Esophagus Using Exhaled Volatile Organic Compound Profiling With an Electronic Nose Device. Gastroenterology 2017, 152(1):24–26.CrossRefPubMed Chan DK, Zakko L, Visrodia KH, Leggett CL, Lutzke LS, Clemens MA, Allen JD, Anderson MA, Wang KK: Breath Testing for Barrett’s Esophagus Using Exhaled Volatile Organic Compound Profiling With an Electronic Nose Device. Gastroenterology 2017, 152(1):24–26.CrossRefPubMed
9.
Zurück zum Zitat Graham D, Lipman G, Sehgal V, Lovat LB: Monitoring the premalignant potential of Barrett’s oesophagus’. Frontline Gastroenterology 2016, 7(4):316–322. Graham D, Lipman G, Sehgal V, Lovat LB: Monitoring the premalignant potential of Barrett’s oesophagus’. Frontline Gastroenterology 2016, 7(4):316–322.
11.
12.
Zurück zum Zitat Ryan M, Gerard K, Amaya-Amaya M: Using Discrete Choice Experiments to Value Health and Health Care. Dordrecht: Springer Netherlands; 2008.CrossRef Ryan M, Gerard K, Amaya-Amaya M: Using Discrete Choice Experiments to Value Health and Health Care. Dordrecht: Springer Netherlands; 2008.CrossRef
13.
Zurück zum Zitat Hall J, Viney R, Haas M, Louviere J: Using stated preference discrete choice modeling to evaluate health care programs. Journal of Business Research 2004, 57(9):1026–1032.CrossRef Hall J, Viney R, Haas M, Louviere J: Using stated preference discrete choice modeling to evaluate health care programs. Journal of Business Research 2004, 57(9):1026–1032.CrossRef
14.
Zurück zum Zitat Wortley S, Wong G, Kieu A, Howard K: Assessing stated preferences for colorectal cancer screening: a critical systematic review of discrete choice experiments. The Patient - Patient-Centered Outcomes Research 2014, 7(3):271–282.CrossRefPubMed Wortley S, Wong G, Kieu A, Howard K: Assessing stated preferences for colorectal cancer screening: a critical systematic review of discrete choice experiments. The Patient - Patient-Centered Outcomes Research 2014, 7(3):271–282.CrossRefPubMed
15.
Zurück zum Zitat Chakraborty G, Ettenson R, Gaeth G: How consumers choose health insurance. J Health Care Mark 1994, 14(1):21–33.PubMed Chakraborty G, Ettenson R, Gaeth G: How consumers choose health insurance. J Health Care Mark 1994, 14(1):21–33.PubMed
16.
Zurück zum Zitat Morgan A, Shackley P, Pickin M, Brazier J: Quantifying patient preferences for out-of-hours primary care. Journal of Health Services Research & Policy 2000, 5(4):214–218.CrossRef Morgan A, Shackley P, Pickin M, Brazier J: Quantifying patient preferences for out-of-hours primary care. Journal of Health Services Research & Policy 2000, 5(4):214–218.CrossRef
17.
Zurück zum Zitat Clark MD, Determann D, Petrou S, Moro D, de Bekker-Grob EW: Discrete Choice Experiments in Health Economics: A Review of the Literature. PharmacoEconomics 2014, 32(9):883–902.CrossRef Clark MD, Determann D, Petrou S, Moro D, de Bekker-Grob EW: Discrete Choice Experiments in Health Economics: A Review of the Literature. PharmacoEconomics 2014, 32(9):883–902.CrossRef
18.
Zurück zum Zitat de Bekker-Grob EW, Ryan M, Gerard K: Discrete choice experiments in health economics: a review of the literature. Health Economics 2012, 21(2):145–172.CrossRefPubMed de Bekker-Grob EW, Ryan M, Gerard K: Discrete choice experiments in health economics: a review of the literature. Health Economics 2012, 21(2):145–172.CrossRefPubMed
19.
Zurück zum Zitat Kruijshaar ME, Essink-Bot ML, Donkers B, Looman CW, Siersema PD, Steyerberg EW: A labelled discrete choice experiment adds realism to the choices presented: preferences for surveillance tests for Barrett esophagus. BMC Medical Research Methodology 2009, 9:31.CrossRefPubMedPubMedCentral Kruijshaar ME, Essink-Bot ML, Donkers B, Looman CW, Siersema PD, Steyerberg EW: A labelled discrete choice experiment adds realism to the choices presented: preferences for surveillance tests for Barrett esophagus. BMC Medical Research Methodology 2009, 9:31.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA: Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value in Health 2007, 10(5):415–430.CrossRefPubMed Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA: Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value in Health 2007, 10(5):415–430.CrossRefPubMed
21.
Zurück zum Zitat Benning TM, Dellaert BGC, Dirksen CD, Severens JL: Preferences for potential innovations in non-invasive colorectal cancer screening: A labeled discrete choice experiment for a Dutch screening campaign. Acta Oncologica 2014, 53(7):898–908.CrossRefPubMed Benning TM, Dellaert BGC, Dirksen CD, Severens JL: Preferences for potential innovations in non-invasive colorectal cancer screening: A labeled discrete choice experiment for a Dutch screening campaign. Acta Oncologica 2014, 53(7):898–908.CrossRefPubMed
22.
Zurück zum Zitat Hol L, de Bekker-Grob EW, van Dam L, Donkers B, Kuipers EJ, Habbema JDF, Steyerberg EW, van Leerdam ME, Essink-Bot ML: Preferences for colorectal cancer screening strategies: a discrete choice experiment. British Journal of Cancer 2010, 102(6):972–980.CrossRefPubMedPubMedCentral Hol L, de Bekker-Grob EW, van Dam L, Donkers B, Kuipers EJ, Habbema JDF, Steyerberg EW, van Leerdam ME, Essink-Bot ML: Preferences for colorectal cancer screening strategies: a discrete choice experiment. British Journal of Cancer 2010, 102(6):972–980.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Pignone MP, Crutchfield TM, Brown PM, Hawley ST, Laping JL, Lewis CL, Lich KH, Richardson LC, Tangka FK, Wheeler SB: Using a discrete choice experiment to inform the design of programs to promote colon cancer screening for vulnerable populations in North Carolina. BMC Health Services Research 2014, 14:611.CrossRefPubMedPubMedCentral Pignone MP, Crutchfield TM, Brown PM, Hawley ST, Laping JL, Lewis CL, Lich KH, Richardson LC, Tangka FK, Wheeler SB: Using a discrete choice experiment to inform the design of programs to promote colon cancer screening for vulnerable populations in North Carolina. BMC Health Services Research 2014, 14:611.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat McFadden D: Conditional logit analysis of qualitative choice behavior. In: Frontiers in Econometrics. edn. Edited by P Z. New York: Academic Press; 1973: 105–142. McFadden D: Conditional logit analysis of qualitative choice behavior. In: Frontiers in Econometrics. edn. Edited by P Z. New York: Academic Press; 1973: 105–142.
25.
Zurück zum Zitat McFadden D, Train K: Mixed MNL models for discrete response. Journal of Applied Econometrics 2000, 15(5):447–470.CrossRef McFadden D, Train K: Mixed MNL models for discrete response. Journal of Applied Econometrics 2000, 15(5):447–470.CrossRef
26.
Zurück zum Zitat Lancsar E, Louviere J: Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. PharmacoEconomics 2008, 26(8):661–677.CrossRefPubMed Lancsar E, Louviere J: Conducting discrete choice experiments to inform healthcare decision making: a user’s guide. PharmacoEconomics 2008, 26(8):661–677.CrossRefPubMed
27.
Zurück zum Zitat Bampton PA, Schloithe A, Bull J, Fraser RJ, Padbury RT, Watson DI: Improving surveillance for Barrett’s oesophagus. BMJ 2006, 332(7553):1320–1323.CrossRefPubMedPubMedCentral Bampton PA, Schloithe A, Bull J, Fraser RJ, Padbury RT, Watson DI: Improving surveillance for Barrett’s oesophagus. BMJ 2006, 332(7553):1320–1323.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat WHO: How to Conduct a Discrete Choice Experiment for Health Workforce Recruitment and Retention in Remote and Rural Areas: A User Guide with Case Studies. Geneva: World Health Organisation 2012. WHO: How to Conduct a Discrete Choice Experiment for Health Workforce Recruitment and Retention in Remote and Rural Areas: A User Guide with Case Studies. Geneva: World Health Organisation 2012.
29.
Zurück zum Zitat Brenner A, Howard K, Lewis C, Sheridan S, Crutchfield T, Hawley S, Reuland D, Kistler C, Pignone M: Comparing 3 values clarification methods for colorectal cancer screening decision-making: a randomized trial in the US and Australia. Journal of General Internal Medicine 2014, 29(3):507–513.CrossRefPubMed Brenner A, Howard K, Lewis C, Sheridan S, Crutchfield T, Hawley S, Reuland D, Kistler C, Pignone M: Comparing 3 values clarification methods for colorectal cancer screening decision-making: a randomized trial in the US and Australia. Journal of General Internal Medicine 2014, 29(3):507–513.CrossRefPubMed
30.
Zurück zum Zitat Salkeld G, Ryan M, Short L: The veil of experience: do consumers prefer what they know best? Health Economics 2000, 9(3):267–270.CrossRefPubMed Salkeld G, Ryan M, Short L: The veil of experience: do consumers prefer what they know best? Health Economics 2000, 9(3):267–270.CrossRefPubMed
31.
Zurück zum Zitat Wortley S, Wong G, Kieu A, Howard K: Assessing stated preferences for colorectal cancer screening: a critical systematic review of discrete choice experiments. The Patient - Patient-Centered Outcomes Research 2014, 7(3):271–282.CrossRefPubMed Wortley S, Wong G, Kieu A, Howard K: Assessing stated preferences for colorectal cancer screening: a critical systematic review of discrete choice experiments. The Patient - Patient-Centered Outcomes Research 2014, 7(3):271–282.CrossRefPubMed
32.
Zurück zum Zitat Lewis CL, Kistler CE, Amick HR, Watson LC, Bynum DL, Walter LC, Pignone MP: Older adults’ attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communities. BMC Geriatrics 2006, 6(1):10.CrossRefPubMedPubMedCentral Lewis CL, Kistler CE, Amick HR, Watson LC, Bynum DL, Walter LC, Pignone MP: Older adults’ attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communities. BMC Geriatrics 2006, 6(1):10.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Boone D, Mallett S, Zhu S, Yao GL, Bell N, Ghanouni A, von Wagner C, Taylor SA, Altman DG, Lilford R: Patients’ & healthcare professionals’ values regarding true-& false-positive diagnosis when colorectal cancer screening by CT colonography: discrete choice experiment. PLoS ONE 2013, 8(12):e80767.CrossRefPubMedPubMedCentral Boone D, Mallett S, Zhu S, Yao GL, Bell N, Ghanouni A, von Wagner C, Taylor SA, Altman DG, Lilford R: Patients’ & healthcare professionals’ values regarding true-& false-positive diagnosis when colorectal cancer screening by CT colonography: discrete choice experiment. PLoS ONE 2013, 8(12):e80767.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Martens CE, Crutchfield TM, Laping JL, Perreras L, Reuland DS, Cubillos L, Pignone MP, Wheeler SB: Why wait until our community gets cancer?: exploring CRC screening barriers and facilitators in the Spanish-speaking community in North Carolina. Journal of Cancer Education 2016, 31(4):652–659.CrossRefPubMedPubMedCentral Martens CE, Crutchfield TM, Laping JL, Perreras L, Reuland DS, Cubillos L, Pignone MP, Wheeler SB: Why wait until our community gets cancer?: exploring CRC screening barriers and facilitators in the Spanish-speaking community in North Carolina. Journal of Cancer Education 2016, 31(4):652–659.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Lancsar EJ, Hall JP, King M, Kenny P, Louviere JJ, Fiebig DG, Hossain I, Thien FC, Reddel HK, Jenkins CR: Using discrete choice experiments to investigate subject preferences for preventive asthma medication. Respirology 2007, 12(1):127–136.CrossRefPubMed Lancsar EJ, Hall JP, King M, Kenny P, Louviere JJ, Fiebig DG, Hossain I, Thien FC, Reddel HK, Jenkins CR: Using discrete choice experiments to investigate subject preferences for preventive asthma medication. Respirology 2007, 12(1):127–136.CrossRefPubMed
Metadaten
Titel
Preferences for Surveillance of Barrett’s Oesophagus: a Discrete Choice Experiment
verfasst von
Norma B. Bulamu
Gang Chen
Tim Bright
Julie Ratcliffe
Adrian Chung
Robert J. L. Fraser
Björn Törnqvist
David I. Watson
Publikationsdatum
26.11.2018
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 7/2019
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-018-4049-6

Weitere Artikel der Ausgabe 7/2019

Journal of Gastrointestinal Surgery 7/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.